Anteotech Ltd · ASX:ADO
Anteotech — Anteo Diagnostics — Shareholder Meeting (November 2017)
7 slides from Anteotech's shareholder meeting presentation, Nov 16, 2017
Slide 1: Chairman's Address and Presentation to Anteo AGM
Chairman’s Address and Presentation to Anteo AGM 16 November 2017 On behalf of Anteo Diagnostics I would like to welcome you to the 2017 Annual general For personal use only meeting. I am Dr John Hurrell Chairman and currently serving as interim Executive Chairman. Firstly, let me introduce the Boar
Slide 2: For personal use only
When I took over the role of Chairman we had a fast diminishing cash balance and loan repayments together with additional earn out obligations coming up with few levers to pull. Anteo lived through some very dark days and survived only because of the support we received from a wide array of people:
Slide 3: For personal use only
commented “Let’s get it right now”. We took a lot of negative comments for this action, but it was the right thing to do long term for the Company. The Company is now ready to re-launch itself, so that we can turn over the reins to the new CEO with tidy finances and sound assets, both in cash reserv
Slide 4: Our Purpose
Our Purpose For personal use only Where we want to be in 2022 Apply Anteo surface technologies to solve important industrial problems and create shareholder value 1
Slide 5: Our Vision
Our Vision For personal use only Where we want to be in 2022 Anteo will be the go-to-provider for innovative surface modification solutions 2
Slide 6: Our Strategic Statement
Our Strategic Statement For personal use only Where we want to be in 2022 We aim to become the leading player in the surface modification technology platform industry by 2022. To do this we shall implement a growth strategy by exploiting our superior ability to innovate, manage our intellectual prop
Slide 7: 2018 Focus
2018 Focus For personal use only o Develop the commercial opportunities for the Anteo technology in the Li-Ion battery industry o Develop the POC relationship discussions into partner agreements o Monetize the ongoing discussions with IVD partners o Initiate Medical Devices partnerships to develop M
Anteo Diagnostics — Shareholder Meeting (November 2017) on 6ix